Skip to main content
Clinical Trials/NCT05664646
NCT05664646
Recruiting
Not Applicable

Autonomic Effects of Transcutaneous Spinal Cord Stimulation in Veterans With SCI

VA Office of Research and Development1 site in 1 country20 target enrollmentJuly 24, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
VA Office of Research and Development
Enrollment
20
Locations
1
Primary Endpoint
Power Output
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

This study aims to determine the effects of transcutaneous spinal cord stimulation to increase blood pressure and use that device to increase power output and heart rate recovery during arm cycle ergometry. In addition, the investigators will see if the stimulation helps regulate body temperature when in a cool environment.

Detailed Description

This study aims to determine the effects of transcutaneous spinal cord stimulation to increase blood pressure and use that device to increase exercise power output and heart rate recovery during arm cycle ergometry. In addition, the investigators will see if the stimulation helps regulate body temperature when in a cool environment. Study 1 (arm cycle ergometry) will consist of 2 visits that will be between 2-3 hours in duration, separated by no less than 3 days, and will consist of putting the electrode at the optimal spot on the spine and completing a submaximal arm ergometry exercise and the other visit will be a sham visit. Study 2 (cool environment) will consist of 2 visits that will be between 3-4 hours in duration, separated by no less than 3 days, and will consist of assessing core temperature when in a cool environment with the stimulator on and off.

Registry
clinicaltrials.gov
Start Date
July 24, 2023
End Date
July 30, 2026
Last Updated
10 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • injury more than 1 year ago, non-ambulatory
  • level of lesion C3-T6, AIS A, B, or C
  • stable prescription medication regimen for at least 30 days
  • must be able to commit to study requirements of 7 visits within a 60-day period

Exclusion Criteria

  • extensive history of seizures
  • ventilator dependence or patent tracheostomy site
  • history of neurologic disorder other than SCI
  • history of moderate or severe head trauma
  • contraindications to spine stimulation
  • significant cardiovascular disease
  • active psychological disorder
  • recent history (within 3 months) of substance abuse
  • open skin lesions over spine at levels targeted for stimulation (L1/L2) and pregnancy

Outcomes

Primary Outcomes

Power Output

Time Frame: through study completion, up to 2 years

Determine if TSCS increases power output (watts) compared to no stimulation.

Total Distance Achieved

Time Frame: through study completion, up to 2 years

Determine if TSCS increases total distance (miles) achieved during arm ergometry compared to no stimulation.

Heart Rate Recovery Time

Time Frame: through study completion, up to 2 years

Determine if TSCS shortens the amount of time for HR recovery (return to baseline) compared to no stimulation.

Body Core Temperature

Time Frame: through study completion, up to 2 years

Determine if TSCS helps maintain body core temperature in a cool environment compared to no stimulation.

Secondary Outcomes

  • Subjective Reporting on Thermal Comfort and Thermal Sensation(through study completion, up to 2 years)
  • Exercise Endurance Time(through study completion, up to 2 years)

Study Sites (1)

Loading locations...

Similar Trials